Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01816932 · ClinicalTrials.gov registry record · NA
Home or Office Visit for the Insertion of Implantable Birth Control
A NA study of Contraception, sponsored by Case Western Reserve University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT01816932: Completed NA study of Contraception, sponsored by Case Western Reserve University.
NCT01816932 is a NA study of Contraception that has completed, run by Case Western Reserve University. The registered enrollment target is 40 participants, below the 454-participant average among 72 other Contraception trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01816932, a NA study of Contraception, has completed, sponsored by Case Western Reserve University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot study in which women who desire an etonogestrel implant will be randomized to either a home or office insertion visit. The purpose of this research is to study the interest in, feasibility of, and rates of insertion for implantable birth control (Implanon®/Nexplanon®) when inserted at home visit appointments compared to standard office visit appointments. The ultimate goal of the study is to reduce barriers to insertion of the etonogestrel implant and increase consistent and correct contraception use by introducing a previously unexplored method of access, the home visit.
Primary Outcome
Assess rates of insertion of etonogestrel contraceptive implant in women randomly assigned to home visits or standard office visits.
Conditions Studied
Interventions
- PROCEDURE Home Visit
- PROCEDURE Office visit
Study Locations (1)
Ohio
- University Hospitals - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2013-06 |
| Est. Completion | 2014-02 |
| Phase | NA |
What the finished NCT01816932 record still lists
NCT01816932 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 454-participant average among 72 other Contraception trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Contraception appearing as the primary indexed condition, and to 2 interventions - of which Home Visit is the first listed.
NCT01816932 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01816932 about?
NCT01816932 is a clinical study titled "Home or Office Visit for the Insertion of Implantable Birth Control". This is a pilot study in which women who desire an etonogestrel implant will be randomized to either a home or office insertion visit. The purpose of this research is to study the interest in, feasibility of, and rates of insertion for implantable birth control (Implanon®/Nexplanon®) when inserted a...
What is the current status of trial NCT01816932?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2013-06. Estimated completion is 2014-02.
What conditions does trial NCT01816932 study?
This clinical trial studies the following conditions: Contraception.
What interventions are being tested in trial NCT01816932?
The interventions under investigation include: Home Visit (PROCEDURE), Office visit (PROCEDURE).
Who is sponsoring clinical trial NCT01816932?
This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01816932 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01816932's enrollment target sits among peer trials
40 55th of 72 higher than 18 of 72 other Contraception trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Contraception trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient-clinical Linkages to Improve Trust and Engagement in Postpartum Healthcare
RECRUITING · NA
-
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
RECRUITING · NA
-
Hormonal Contraception Access Through Pharmacist Prescribing Implementation
RECRUITING · NA
-
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
RECRUITING · NA
-
Contraceptive Efficacy Study of Ovaprene
RECRUITING · NA
-
Intervening on Women's Health for Rural Young Cancer Survivors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia